Parsec Financial Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | $1.1M | Sell |
1,906
-51
| -3% | -$28.7K | 0.05% | 156 |
|
|
2022
Q4 | $1.08M | Sell |
1,957
-66
| -3% | -$35K | 0.05% | 160 |
|
|
2022
Q3 | $1.03M | Hold |
2,023
| – | – | 0.05% | 159 |
|
|
2022
Q2 | $1.1M | Buy |
2,023
+3
| +0.1% | +$1.65K | 0.05% | 161 |
|
|
2022
Q1 | $1.19M | Buy |
2,020
+126
| +7% | +$72.4K | 0.05% | 166 |
|
|
2021
Q4 | $1.26M | Hold |
1,894
| – | – | 0.05% | 154 |
|
|
2021
Q3 | $1.17M | Hold |
1,894
| – | – | 0.05% | 151 |
|
|
2021
Q2 | $955K | Sell |
1,894
-11
| -0.6% | -$5.19K | 0.05% | 151 |
|
|
2021
Q1 | $869K | Buy |
1,905
+13
| +0.7% | +$6.21K | 0.04% | 146 |
|
|
2020
Q4 | $881K | Sell |
1,892
-120
| -6% | -$56.3K | 0.05% | 139 |
|
|
2020
Q3 | $888K | Buy |
2,012
+80
| +4% | +$33.1K | 0.05% | 136 |
|
|
2020
Q2 | $700K | Sell |
1,932
-63
| -3% | -$21.1K | 0.04% | 145 |
|
|
2020
Q1 | $566K | Sell |
1,995
-32
| -2% | -$10.1K | 0.04% | 153 |
|
|
2019
Q4 | $659K | Hold |
2,027
| – | – | 0.04% | 155 |
|
|
2019
Q3 | $590K | Sell |
2,027
-100
| -5% | -$28.6K | 0.04% | 161 |
|
|
2019
Q2 | $625K | Sell |
2,127
-5
| -0.2% | -$1.38K | 0.04% | 160 |
|
|
2019
Q1 | $584K | Buy |
2,132
+6
| +0.3% | +$1.49K | 0.04% | 160 |
|
|
2018
Q4 | $476K | Sell |
2,126
-70
| -3% | -$16.4K | 0.03% | 170 |
|
|
2018
Q3 | $536K | Sell |
2,196
-33
| -1% | -$7.59K | 0.03% | 173 |
|
|
2018
Q2 | $462K | Buy |
2,229
+131
| +6% | +$27.8K | 0.03% | 179 |
|
|
2018
Q1 | $433K | Buy |
2,098
+5
| +0.2% | +$1.05K | 0.03% | 185 |
|
|
2017
Q4 | $397K | Hold |
2,093
| – | – | 0.03% | 193 |
|
|
2017
Q3 | $396K | Hold |
2,093
| – | – | 0.03% | 195 |
|
|
2017
Q2 | $365K | Buy |
2,093
+163
| +8% | +$27.4K | 0.03% | 163 |
|
|
2017
Q1 | $296K | Hold |
1,930
| – | – | 0.02% | 168 |
|
|
2016
Q4 | $272K | Sell |
1,930
-8
| -0.4% | -$1.18K | 0.02% | 175 |
|
|
2016
Q3 | $308K | Buy |
1,938
+12
| +0.6% | +$1.85K | 0.03% | 168 |
|
|
2016
Q2 | $285K | Sell |
1,926
-687
| -26% | -$101K | 0.03% | 161 |
|
|
2016
Q1 | $370K | Hold |
2,613
| – | – | 0.04% | 146 |
|
|
2015
Q4 | $371K | Buy |
2,613
+17
| +0.7% | +$2.27K | 0.04% | 142 |
|
|
2015
Q3 | $317K | Buy |
2,596
+678
| +35% | +$88.3K | 0.03% | 146 |
|
|
2015
Q2 | $249K | Hold |
1,918
| – | – | 0.03% | 159 |
|
|
2015
Q1 | $258K | Buy |
1,918
+49
| +3% | +$6.32K | 0.03% | 156 |
|
|
2014
Q4 | $234K | Hold |
1,869
| – | – | 0.02% | 150 |
|
|
2014
Q3 | $227K | Sell |
1,869
-50
| -3% | -$6.08K | 0.02% | 150 |
|
|
2014
Q2 | $226K | Sell |
1,919
-125
| -6% | -$14.7K | 0.02% | 151 |
|
|
2014
Q1 | $246K | Buy |
2,044
+5
| +0.2% | +$594 | 0.03% | 142 |
|
|
2013
Q4 | $227K | Buy |
+2,039
| New | +$203K | 0.03% | 136 |
|
|
2013
Q3 | – | Sell |
-2,694
| Closed | -$228K | – | 136 |
|
|
2013
Q2 | $228K | Buy |
+2,694
| New | +$224K | 0.03% | 124 |
|
Other funds holding TMO
Parsec Financial Management's TMO Position: Q1 2023 in Review
Parsec Financial Management reduced its Thermo Fisher Scientific (TMO) stake by 2.6% in Q1 2023, selling an estimated $28.7K and leaving 1,906 shares worth $1.1M. The position accounts for 0.05% of the portfolio, ranked #156.
Parsec Financial Management first reported a position in TMO in Q2 2013 and has held it in 39 quarters since. The position peaked at $1.26M in Q4 2021. 2,385 funds tracked by Wall St. Rank hold TMO as of Q1 2023.
- Parsec Financial Management held 1,906 shares of Thermo Fisher Scientific worth $1.1M as of Q1 2023.
- Parsec Financial Management sold 51 Thermo Fisher Scientific shares in Q1 2023, an estimated $28.7K.
- Thermo Fisher Scientific made up 0.05% of Parsec Financial Management's portfolio in Q1 2023, its #156 holding.
- Parsec Financial Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 39 quarters since.
- Parsec Financial Management's Thermo Fisher Scientific position peaked at $1.26M in Q4 2021.
- 2,385 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2023.
Based on Parsec Financial Management's 13F filing for Q1 2023, filed 6 Apr 2023.